OncoMatch/Clinical Trials/Leukemia — Acute Myeloid (AML)
Leukemia — Acute Myeloid (AML) Clinical Trials
OncoMatch filters Leukemia — Acute Myeloid (AML) trials by the molecular markers that determine eligibility — FLT3, IDH1, IDH2, NPM1, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Leukemia — Acute Myeloid (AML) trials
These are the molecular markers most commonly required or evaluated in Leukemia — Acute Myeloid (AML) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Leukemia — Acute Myeloid (AML) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Oncology Group
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Oncology Group
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Children's Oncology Group
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Daiichi Sankyo
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
PedAL BCU, LLC
How OncoMatch finds Leukemia — Acute Myeloid (AML) trials for you
AI reads the protocol
Every Leukemia — Acute Myeloid (AML) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Leukemia — Acute Myeloid (AML) and mark your biomarker results — FLT3, IDH1, IDH2 — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.